Amag Pharmaceuticals Inc. (NASDAQ: AMAG) announced the company has priced a public offering of 3.6 million common shares at $48.25 per share.
The biopharmaceutical company said late Wednesday that the offering's size had been increased by 600,000 shares.
Top Best Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign up for our Free Stock Newsletter.
Amag gave the underwriters an option to buy up to an additional 540,000 shares to cover any overallotments.
The offering is expected to close on Jan. 26.
Shares of Amag Pharmaceuticals closed Wednesday at $49.28.
Sign up for Top Best Penny Stocks' free newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
Follow us on Twitter: http://www.Twitter.com/topbestps
About Us
Top Best Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
